Spotting Transformative Innovations

Nearly every healthcare company promotes itself as a game-changer, but of course few are. Over the past decade, I have focused on identifying and vetting “high-performing” healthcare organizations. I mean this term to refer to firms that consistently deliver measurably better health outcomes and/or lower costs than conventional approaches, particularly in high-value niches – e.g., management of chronic disease, musculoskeletal conditions, cancer and other complex diseases, maternity, drug spending) – areas that comprise healthcare’s greatest costs.